Free shipping on all orders over $ 500

JTE 013

Cat. No. M2787
JTE 013 Structure
Size Price Availability Quantity
5mg USD 80  USD80 In stock
10mg USD 110  USD110 In stock
25mg USD 240  USD240 In stock
50mg USD 440  USD440 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

JTE 013 is a potent and selective S1P2 antagonist with IC50 of 17.6 nM.

Customer Product Validations & Biological Datas
Source J Neurophysiol (2012). Figure 1. JTE 013
Method RT-PCR
Cell Lines sensory neurons
Concentrations 100 nM
Incubation Time 15-min
Results The number of APs at each time point was then normalized to the respective control values, and this analysis demonstrated that JTE-013 produced a rapid and significant increase in excitability in 70% of the sensory neurons compared with their control values
Chemical Information
Molecular Weight 408.29
Formula C17H19Cl2N7O
CAS Number 383150-41-2
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Mei-Hong Li, et al. J Pharmacol Exp Ther . Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma

[2] Jen-Fu Lee, et al. Am J Physiol Heart Circ Physiol . Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature

[3] Melissa R Pitman, et al. The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism

[4] Qiumin Xu, et al. JTE-013 Alleviates Inflammatory Injury and Endothelial Dysfunction Induced by Sepsis In Vivo and In Vitro

[5] Meng Pang, et al. Inhibitory Effect of S1PR2 Antagonist JTE-013 on Proliferation of Chronic Myeloid Leukemia Cells

[6] Jisoo Kang, et al. Topical Application of S1P 2 Antagonist JTE-013 Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice

[7] K Liu, et al. JTE-013 supplementation improves erectile dysfunction in rats with streptozotocin-induced type Ⅰ diabetes through the inhibition of the rho-kinase pathway, fibrosis, and apoptosis

Related S1P Receptor Products
VTX-002

VTX-002 is an orally active, selective S1P receptor 1 modulator for studies related to ulcerative colitis.

TRV045

TRV045 is an S1P receptor modulator that can be used in studies related to central nervous system disorders.

S1PR1 modulator 1 

S1PR1 modulator 1 is a selective S1PR1 inhibitor, with a pIC50 of 7.6, with >40- and >80-fold selectivity, over the other S1PR isoforms S1PR2/3/4.

Ozanimod hydrochloride

Ozanimod (RPC-1063) hydrochloride, a sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity selectively to S1P receptor subtypes 1 (S1P1) and 5 (S1P5). Ozanimod hydrochloride has modulate effect for hS1P1 and hS1P5 receptor with EC50s of 1.03 nM and 8.6 nM, respectively. Ozanimod hydrochloride can be used for the research of relapsing multiple sclerosis (MS) .

Icanbelimod

Icanbelimod (S1p receptor agonist 1) is a potent and orally active S1P1 receptor agonist, exhibits an activity of inducing S1P1 internalization (EC50=9.83 nM). Icanbelimod has the potential for the study of arthritis and EAE (experimental autoimmune encephalitis).

  Catalog
Abmole Inhibitor Catalog




Keywords: JTE 013 supplier, S1P Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.